C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/1998
09/23/1998	CN1194002A Phenylacetyl-CoA ligase from penicillium chrysogenum
09/23/1998	CN1194001A Neutralizing conformational epitopes of chicken anemia virus
09/23/1998	CN1194000A Methods for enhancement of protective immune responses
09/23/1998	CN1193999A Expression of ocean fish antifreeze peptide in food grade organism and its application in food products
09/23/1998	CN1193998A Bioprocess for producing dipeptide based compounds
09/23/1998	CN1193997A Methodology to produce, purify and assay polypeptides with proteolytic activity of HCV NS3 protease
09/23/1998	CN1193995A Separation and concentration systems based on soluble oligosaccharide binding domains
09/23/1998	CN1193981A Human g-protein coupled receptor (HETGQ 23)
09/23/1998	CN1193980A G-protein receptor HTNAD 29
09/23/1998	CN1193915A Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
09/23/1998	CN1193659A IV collagen enzyme specific antibody for human gene engineering
09/22/1998	US5811654 Plants genetically enhanced for nutritional quality
09/22/1998	US5811653 Viral amplification of recombinant messenger RNA in transgenic plants
09/22/1998	US5811636 Apomixis for producing true-breeding plant progenies
09/22/1998	US5811634 Transgenic mammal encoding ornithine decarboxylase
09/22/1998	US5811633 Transgenic mouse expressing APP770
09/22/1998	US5811632 Non-human mammalian model for human papillomavirus-induced disease
09/22/1998	US5811538 Process for the purification of oligomers
09/22/1998	US5811537 Antisense oligonucleotides targeted against human immunodeficiency virus
09/22/1998	US5811536 Cauliflower floral meristem identity genes and methods of using same
09/22/1998	US5811535 Human cartilege gp39-like gene
09/22/1998	US5811534 Purine-based compounds for inclusion into oligonucleotides
09/22/1998	US5811533 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
09/22/1998	US5811524 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
09/22/1998	US5811522 Recombinant humanized anti-FB5 antibodies
09/22/1998	US5811520 Human phospholipase inhibitor protein
09/22/1998	US5811518 Polypeptide having specified amino acid sequence, capable of being specifically bound by antibody
09/22/1998	US5811517 Polynucleotides encoding intercellular adhesion molecule, and variants which display one or more ligand/receptor binding biological activities; cytoplasmic tail variants
09/22/1998	US5811407 Using alphaviruses as vectors containing immunogenic or therapeutic proteins;
09/22/1998	US5811406 Stabilized by adding cryoprotectant and lyophilizing; delivering to cell tissue
09/22/1998	US5811397 Mammalian augmenter of liver regeneration and variants thereof
09/22/1998	US5811393 Heparin binding mitogen with homology to epidermal growth factor (EGF)
09/22/1998	US5811381 Cellulase compositions and methods of use
09/22/1998	US5811304 Nucleic acid molecules encoding retinoblastoma protein-interacting zinc finger proteins
09/22/1998	US5811300 TNF-α ribozymes
09/22/1998	US5811297 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
09/22/1998	US5811291 Enzyme with rhamnogalacturonase activity
09/22/1998	US5811288 Isoform gene for focal adhesion protein paxillin
09/22/1998	US5811286 Nucleic acid fragments encoding stereospecific nitrile hydratase and amidase enzymes and recombinant organisms expressing those enzymes useful for the production of chiral amides and acids
09/22/1998	US5811285 Dna molecule which codes biocatalyst which selectively desulfurizes fossil fuel containing sulfur
09/22/1998	US5811281 Immortalized intestinal epithelial cell lines
09/22/1998	US5811275 HIV-specific ribozymes
09/22/1998	US5811274 Depositing viral particles or carriers on cell growth support, contacting target cells; efficiency;
09/22/1998	US5811273 DNA strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls
09/22/1998	US5811270 In vitro method for concerted integration of donor DNA molecules using retroviral integrase proteins
09/22/1998	US5811269 Detection of mycobacteria by multiplex nucleic acid amplification
09/22/1998	US5811268 Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids
09/22/1998	US5811267 For drug or toxin targeting, imaging, therapy
09/22/1998	US5811266 Methods for producing human insulin
09/22/1998	US5811264 Mutated protein having sequence with nonproline amino acid replacement for proline at position four, which is not methylated at its n-terminus when expressed in bacteria
09/22/1998	US5811263 A cloned dna molecule which encodes human endothelin-3-protein; hypertensive agents and has a antivasoconstrictor activity
09/22/1998	US5811262 Hepatocellular carcinoma oncogene
09/22/1998	US5811261 Transfecting eukaryotic cells with an expression vector
09/22/1998	US5811260 Exogenous gene expression vector containing chick β-actin gene promoter
09/22/1998	US5811245 Antibodies that specifically bind to ALK-7, a novel serine threonine kinase receptor
09/22/1998	US5811238 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
09/22/1998	US5811237 Sequence coding for protein expressed by campylobacter pylori
09/22/1998	US5811235 Amplification of tandemly repeated region of genomic dna, separation of set of amplification products to provide sample code
09/22/1998	US5811234 Methods and applications for efficient genetic suppressor elements
09/22/1998	US5811231 Methods and kits for eukaryotic gene profiling
09/22/1998	US5811106 Polypeptides produced by human malaria parasites
09/22/1998	US5811104 Efficacious vaccine against feline infectious peritonitis virus; manipulation to generate an immune response.
09/22/1998	US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling
09/22/1998	CA2037244C Method for purifying somatotropin monomers
09/22/1998	CA2009752C Effluent treatment system
09/21/1998	CA2232828A1 Humanized anti-human fas antibody
09/21/1998	CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein
09/19/1998	CA2226399A1 Escherichia coli mutant
09/19/1998	CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor
09/17/1998	WO1998040744A1 Method for simultaneous detection of hiv antigens and hiv antibodies
09/17/1998	WO1998040519A1 Intron-mediated recombinant techniques and reagents
09/17/1998	WO1998040516A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
09/17/1998	WO1998040510A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell
09/17/1998	WO1998040509A1 Chimeric adenoviral coat protein and methods of using same
09/17/1998	WO1998040508A1 Adenoviral vectors with modified tropism
09/17/1998	WO1998040507A1 Expression of a modified foamy virus envelope protein
09/17/1998	WO1998040506A1 Use of an acute phase serum amyloid a gene promoter (a-saa promoter) in the treatment of diseases in mammals
09/17/1998	WO1998040505A1 Maize dimboa biosynthesis genes
09/17/1998	WO1998040504A1 Methods for altering benzoxazinone levels in plants
09/17/1998	WO1998040503A1 Nucleic acid molecules encoding starch phosphorylase from maize
09/17/1998	WO1998040502A1 Peptide-enhanced transfections
09/17/1998	WO1998040501A1 Vectors having enhanced expression, and methods of making and uses thereof
09/17/1998	WO1998040500A1 Vectors having enhanced expression and methods of making and uses thereof
09/17/1998	WO1998040499A1 Gene delivery to mucosal epithelium for immunization or therapeutic purposes
09/17/1998	WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
09/17/1998	WO1998040496A1 Dna polymerases having improved labeled nucleotide incorporation properties
09/17/1998	WO1998040495A1 Doublin, a gene involved in neuronal development and uses therefor
09/17/1998	WO1998040494A1 Novel rna editing enzyme
09/17/1998	WO1998040493A1 Fiv vaccine
09/17/1998	WO1998040492A1 Compositions and methods for elimination of unwanted cells
09/17/1998	WO1998040491A2 Pesticidal bacillus thuringiensis strains
09/17/1998	WO1998040490A1 Bacillus thuringiensis toxins
09/17/1998	WO1998040489A1 Antisense base sequences
09/17/1998	WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies
09/17/1998	WO1998040487A1 Angiogenin receptor, compositions and methods related thereto
09/17/1998	WO1998040486A2 Secreted proteins and polynucleotides encoding them
09/17/1998	WO1998040485A1 Human secreted protein, ba3.1, and polynucleotides encoding same
09/17/1998	WO1998040484A1 Intracellular amyloid-beta binding (erab) polypeptide
09/17/1998	WO1998040483A2 28 human secreted proteins
09/17/1998	WO1998040482A1 Growth factor receptor binding protein

1 ... 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 ... 4023